Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Inhibitex

Inhibitex is a clinical-stage biopharmaceutical company dedicated to the development of innovative products that can treat or prevent

Acquired by Bristol-Myers Squibb on January 07, 2012

Website: https://temporal-url-9999999.com

Founded: January 01, 1994

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
NarcX	Pharmaceuticals & Biotechnology	Be Part of the Solution - NarcX is the only solution that destroys and dispo ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount
Oct 28, 2009	Venture	$ 23,000,000
Jan 08, 2004	Series E	$ 18,250,000
Apr 18, 2002	Series D	$ 45,000,000

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Joseph Patti	Founder	Unknown to Unknown